93 related articles for article (PubMed ID: 3246053)
1. Release rates of indomethacin from commercial witepsol suppositories and the bioavailabilities in rabbits and pigs.
Aoyagi N; Kaniwa N; Takeda Y; Uchiyama M; Takamura F; Kido Y
Chem Pharm Bull (Tokyo); 1988 Dec; 36(12):4933-40. PubMed ID: 3246053
[No Abstract] [Full Text] [Related]
2. Study on absorption of indomethacin from sustained-release suppositories containing hydrogenated soybean lecithin in rabbits.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3145-7. PubMed ID: 2632063
[TBL] [Abstract][Full Text] [Related]
3. Preparation of sustained-release suppositories containing microencapsulated indomethacin and bioavailability of indomethacin in rabbits.
Nakajima T; Takashima Y; Iida K; Mitsuta H; Furuya A; Koishi M
Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4249-54. PubMed ID: 3435949
[No Abstract] [Full Text] [Related]
4. In vivo and in vitro release of indomethacin from water-soluble and fatty base suppositories.
Furuno K; Gomita Y; Yoshida T; Oishi R; Saeki K; Araki Y
Acta Med Okayama; 1992 Aug; 46(4):223-31. PubMed ID: 1442146
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin sustained-release suppositories containing sugar ester.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):1027-31. PubMed ID: 2379274
[TBL] [Abstract][Full Text] [Related]
6. Influence of storage temperature on indomethacin release from fatty-base suppositories in vitro and in vivo.
Yoshida T; Itoh Y; Gomita Y; Oishi R
Acta Med Okayama; 1991 Feb; 45(1):37-42. PubMed ID: 2063694
[TBL] [Abstract][Full Text] [Related]
7. Effect of the molecular weight of polyethylene glycol on the bioavailability of indomethacin sustained-release suppositories prepared with solid dispersions.
Ohnishi N; Kiyohara Y; Kita Y; Kuroda K; Yokoyama T
Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3511-5. PubMed ID: 3427728
[No Abstract] [Full Text] [Related]
8. In vitro drug liberation and kinetics of sustained release indomethacin suppository.
Uzunkaya G; Bergişadi N
Farmaco; 2003 Jul; 58(7):509-12. PubMed ID: 12818689
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of indomethacin sustained-release suppositories using a hydroxypropylmethylcellulose acetate succinate-polyethylene glycol 2000 solid matrix.
Ohnishi N; Kiyohara Y; Kita Y; Kuroda K; Yokoyama T
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3935-9. PubMed ID: 3435990
[No Abstract] [Full Text] [Related]
10. Indomethacin sustained-release suppositories containing sugar ester in polyethylene glycol base.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1680-3. PubMed ID: 2208382
[TBL] [Abstract][Full Text] [Related]
11. Preparation of sustained-release suppositories of indomethacin using a solid dispersion system and evaluation of bioavailability in rabbits.
Ohnishi N; Yokoyama T; Umeda T; Kiyohara Y; Kuroda T; Kita Y; Kuroda K
Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2999-3004. PubMed ID: 3769103
[No Abstract] [Full Text] [Related]
12. Studies on sustained-release dosage forms. I. Preparation and bioavailability of indomethacin suppositories.
Umeda T; Matsuzawa A; Yokoyama T; Kuroda K; Kuroda T
Chem Pharm Bull (Tokyo); 1983 Aug; 31(8):2793-8. PubMed ID: 6652823
[No Abstract] [Full Text] [Related]
13. Evaluation of indomethacin sustained-release suppositories prepared with a methacrylic acid-methacrylic acid methyl ester copolymer-polyethylene glycol 2000 solid matrix.
Ohnishi N; Yokoyama T; Kiyohara Y; Okumura K; Kuroda K
Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):430-4. PubMed ID: 3378304
[No Abstract] [Full Text] [Related]
14. Medicament release from suppository bases I: Physicochemical characteristics and bioavailability of indomethacin in rabbits.
Vidras NJ; Reid VE; Bohidar NR; Plakogiannis FM
J Pharm Sci; 1982 Aug; 71(8):945-9. PubMed ID: 7120104
[TBL] [Abstract][Full Text] [Related]
15. Pluronic F-127 gels as a novel vehicle for rectal administration of indomethacin.
Miyazaki S; Yokouchi C; Nakamura T; Hashiguchi N; Hou WM; Takada M
Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1801-8. PubMed ID: 3719880
[No Abstract] [Full Text] [Related]
16. [Pharmaceutical evaluation of a hollow type suppository. II. Indomethacin added form and release characteristics of the hollow type suppository].
Watanabe Y; Yokoyama K; Yamaji M; Tanaka F; Matsumoto M
Yakugaku Zasshi; 1985 Mar; 105(3):278-83. PubMed ID: 4032232
[No Abstract] [Full Text] [Related]
17. [Pharmaceutical evaluation of a hollow type suppository. III. Effect of macrogol 300 on the bioavailability of indomethacin in rabbits].
Watanabe Y; Tone Y; Suzuki M; Matsumoto M
Yakugaku Zasshi; 1985 Mar; 105(3):284-8. PubMed ID: 4032233
[No Abstract] [Full Text] [Related]
18. [Changes in physiochemical properties of shelved oleaginous suppository bases: the effects on indomethacin, aminopyrine and sulpyrine release rates].
Ejima A; Tatsuzawa M; Ogata H; Aoyagi N; Kaniwa N; Matsuda R
Eisei Shikenjo Hokoku; 1983; (101):75-9. PubMed ID: 6675777
[No Abstract] [Full Text] [Related]
19. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability studies on fast release formulations of indomethacin.
Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
Boll Chim Farm; 2002; 141(3):176-80. PubMed ID: 12197414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
